IG asked to probe Graham harassment

Share this article:
Finance Committee chairman Sen. Chuck Grassley (R-IA) has asked the HHS inspector general to find out how an FDA employee worked "in concert with a pharmaceutical drug maker to discredit the FDA scientist who publicized information about the safety risks of the drug Vioxx."

The request was based on the handwritten notes of a Merck executive about his meeting with a high-level FDA official that indicated the FDA official had suggested the firm release its critique of Dr. David Graham. “This evidence makes it look like FDA hung Dr. Graham out to dry,” the senator said. “If so, the message sent to the rank-and-file is, ‘We're not with you, we're with the industry.'”

The Merck executive was named as Dr. Ned Braunstein, Merck Research Labs senior director; and the FDA official as Dr. Brian Harvey, director of the Division of Gastrointestinal and Coagulation Drug Products.

Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.